Inhaled “Muco‐Trapping” Monoclonal Antibody Effectively Treats Established Respiratory Syncytial Virus (RSV) Infections
Article in Advanced Science (January 2024)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Cationic-nanogel nasal vaccine containing the ectodomain of RSV-small hydrophobic protein induces protective immunity in rodents
Article in npj Vaccines (July 2023)
From animal studies into clinical trials: the relevance of animal models to develop vaccines and therapies to reduce disease severity and prevent hRSV infection
Article in Expert Opinion on Drug Discovery (September 2022)